1. Soluble immune checkpoints CD27, Lag3, PD-L2 and Tim3 in early stage NSCLC patients. (March 2018) Authors: Gamerith, G.; Hackl, H.; Wallinger, P.; Fandel, L.; Kern, J.; Augustin, F.; Lorenz, E.; Hoflehner, E.; Mildner, F.; Moser, P.; Sprung, S.; Zelger, B.; Köck, S.; Amann, A.; Schäfer, G.; Öfner, D.; Maier, H.; Trajanoski, Z.; Zwierzina, H.; Sopper, S. Journal: European journal of cancer Issue: Volume 92(2018)Supplement 1 Page Start: S12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗